| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes
|
Dykes, Kaitlyn
|
|
|
22 |
5 |
p. e314-e320
|
artikel
|
| 2 |
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group
|
Michallet, Mauricette
|
|
|
22 |
5 |
p. 311-318
|
artikel
|
| 3 |
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
|
Bennani, N. Nora
|
|
|
22 |
5 |
p. e300-e309
|
artikel
|
| 4 |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma
|
Zhao, Yue
|
|
|
22 |
5 |
p. e310-e313
|
artikel
|
| 5 |
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
|
Costa, Luciano J.
|
|
|
22 |
5 |
p. 326-335
|
artikel
|
| 6 |
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
|
Al-Shaibani, Eshrak
|
|
|
22 |
5 |
p. e327-e334
|
artikel
|
| 7 |
COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination
|
Shah, Mansi R.
|
|
|
22 |
5 |
p. e321-e326
|
artikel
|
| 8 |
Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States
|
Dhakal, Prajwal
|
|
|
22 |
5 |
p. 319-325
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
22 |
5 |
p. A1-A2
|
artikel
|
| 10 |
Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
|
Ehsan, Hamid
|
|
|
22 |
5 |
p. e285-e292
|
artikel
|
| 11 |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations
|
Polprasert, Chantana
|
|
|
22 |
5 |
p. e293-e299
|
artikel
|
| 12 |
Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors
|
Spallone, Amy
|
|
|
22 |
5 |
p. 305-310
|
artikel
|
| 13 |
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
|
Jurczyszyn, Artur
|
|
|
22 |
5 |
p. 297-304
|
artikel
|
| 14 |
Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review
|
Albano, Domenico
|
|
|
22 |
5 |
p. e340-e349
|
artikel
|
| 15 |
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 – 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study
|
Talpaz, Moshe
|
|
|
22 |
5 |
p. 336-346
|
artikel
|
| 16 |
SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas
|
Qiu, Lianqun
|
|
|
22 |
5 |
p. 287-296
|
artikel
|
| 17 |
SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma
|
Grant, Shakira J.
|
|
|
22 |
5 |
p. 279-286
|
artikel
|
| 18 |
State-of-the-Art Review on Myelofibrosis Therapies
|
Wang, Fuping
|
|
|
22 |
5 |
p. e350-e362
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
22 |
5 |
p. A3-A4
|
artikel
|
| 20 |
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
|
Caimi, Paolo F.
|
|
|
22 |
5 |
p. e335-e339
|
artikel
|
Tijdschrift beschrijving